On the HCPLive Internal Medicine condition center page, resources on the topics of medical news and expert insight into internal medicine can be found. Content includes articles, interviews, videos, podcasts, and breaking news on internal medicine research, treatment, and drug development.
May 20th 2024
Use of dupilumab reduced exacerbations and improved lung function in COPD patients with type 2 inflammation.
Advancing Care in Erosive Esophagitis: Towards a Path of Complete Healing
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
October 16, 2024
Register Now!
Shaping the Management of COPD with Biologic Therapy
View More
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Expert Illustrations & Commentaries™: Exploring the Role of Novel Agents for the Management of IgA Nephropathy
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More
Patient, Provider & Caregiver Connection™: Implementing an Effective Management Plan to Improve Outcomes in IgA Nephropathy
View More
Artificial Intelligence Tools Could Use ECGs to Predict Type 2, Prediabetes
August 10th 2022Called the DiaBeats algorithm, new research suggests leveraging the machine learning-based algorithm, combined with ECG recordings, could help predict increased risk of developing prediabetes and type 2 diabetes.
GnRH Agonists for Prostate Cancer Could Increase CVD Risk in Type 2 Diabetes
August 9th 2022New research suggests there was a 53% greater 5-year risk of cardiovascular disease in men with type 2 diabetes who received a GnRH agonist for prostate cancer compared with their counterparts who did not receive GnRH agonists.
Trial Suggests Time-Restricted Eating Could Aid in Weight Loss, Improve Blood Pressure
August 8th 2022Data from a 14-week randomized clinical trial suggests adherence to a time-restricted diet was associated with significant differences in weight loss and improvements in blood pressure compared to a typical diet.
CDC will Include New ICD-10-CM Diagnosis Code for a Rare Disease in Fall
August 5th 2022In October, a new ICD-10-CM diagnosis code will be activated for APDS, a rare primary immunodeficiency disease, which will enable physicians and payers to add the diagnosis to patient charts for the first time in the US.
Blood Protein Could Signal Increased Risk of Diabetes, Future Cancer Mortality
August 5th 2022An analysis of more than 20 years of follow-up data from more than 4000 patients in the Malmö Diet and Cancer Study shed light on associations between prostasin concentrations and risk of developing diabetes and cancer mortality.
CGM Can Improve Glucose Control, Reduce Spread of Infectious Disease in In-Hospital Settings
August 3rd 2022A retrospective study provides insight into the ability of CGM technology to improve glycemic control in in-hospital settings and, potentially, reduce the risk of spreading infectious diseases.
Thiopurine Metabolic Monitoring Leads to Higher Remission of IBD
Repeated metabolite monitoring with subsequent dose optimization resulted in 67.2% of patients achieving therapeutic levels after 1 year and 87.8% of patients achieving steroid-free remission, while 90% had no therapy escalation or surgery.
Long-Acting Injectables Reduce Disease Relapse in Schizophrenia
Patients treated with LAIAs had a lower risk of hospitalization for any cause, hospitalizations for psychiatric disorders, hospitalizations for schizophrenia, and incident suicide attempts compared to patients treated with oral antipsychotics.
Poor Sleep Habits, Behaviors Could Increase Risk of Fatty Liver Disease
August 1st 2022An analysis of a prospective cohort study in China provides evidence suggesting poor sleep behaviors, including daytime napping and nighttime sleep disturbances, could increase risk of metabolic dysfunction-associated fatty liver disease.
No-Cost, Fully Automated Weight Loss Programs Show Promise in Primary Care Setting
July 29th 2022A trial assessing a 12-week fully automated, no-cost online education program suggests participation in the program was linked to a mean weight loss of 5.1% of starting body weight, with greater levels of participation linked to greater weight loss among participants.
Hormone Replacement Therapy Does Not Increase Breast Cancer Recurrence, Mortality in Survivors
July 20th 2022An analysis of data from more than 8400 postmenopausal women with a history of early-stage nonmetastatic, ER-positive breast cancer suggests there was no increase in risk of breast cancer recurrence or mortality observed with use of vaginal estrogen therapy or menopausal hormone therapy.